MDT
83.85
-0.46%↓
VEEV
224.68
-0.35%↓
A
105.25
-0.38%↓
WBA
11
+0.36%↑
CHE
545.53
-2.68%↓
MDT
83.85
-0.46%↓
VEEV
224.68
-0.35%↓
A
105.25
-0.38%↓
WBA
11
+0.36%↑
CHE
545.53
-2.68%↓
MDT
83.85
-0.46%↓
VEEV
224.68
-0.35%↓
A
105.25
-0.38%↓
WBA
11
+0.36%↑
CHE
545.53
-2.68%↓
MDT
83.85
-0.46%↓
VEEV
224.68
-0.35%↓
A
105.25
-0.38%↓
WBA
11
+0.36%↑
CHE
545.53
-2.68%↓
MDT
83.85
-0.46%↓
VEEV
224.68
-0.35%↓
A
105.25
-0.38%↓
WBA
11
+0.36%↑
CHE
545.53
-2.68%↓
24h
Actual
Mínimo
1.59
Máximo
1.66
Recomendaciones | Comprar |
---|---|
Estimación a 12 meses | +863.86% upside |
El rendimiento pasado no es un indicador fiable de resultados futuros.
10 mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Leer
10 mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
10 mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
Cambio de precio
By TipRanks
Estimación a 12 meses
Media 16 USD 863.86%
Máximo 16 USD
Mínimo 16 USD
De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Fortress Biotech Inc Dist en los últimos 3 meses.
By TipRanks
Comprar
1 ratings
1
Comprar
0
Mantener
0
Vender
De acuerdo con 1 analistas que ofrecen calificaciones bursátiles a para Fortress Biotech Inc Dist en los últimos 3 meses.
$